Event Title

Amplichip: Diagnostic Tool of the Future

Location

CSU 204

Start Date

26-4-2005 8:30 AM

End Date

26-4-2005 10:00 AM

Student's Major

Communication Studies

Student's College

Arts and Humanities

Mentor's Name

James Dimock

Mentor's Department

Communication Studies

Mentor's College

Arts and Humanities

Description

Adverse drug reactions, or ADRs, are the fourth leading cause of death in the. United-States according to Drug Discovery and Development of October 1, 2004, but new technology provides an opportunity to change that statistic. Personalized medicine, has the huge potential to change the lives of millions of people with a testing device manufactured by Roche Diagnostics known as Amplichip. Amplichip is a simple blood-testing device that provides doctors with important information about how patients process medications. Heino von Prondzynski, CEO of Roche Diagnostics, says of Amplichip, "The use of this test takes a big-step forward in making personalized medicine a reality n and has the potential to improve patient outcomes." Testing with Amplichip will soon be a routine diagnostic procedure that will have impact on millions of people. In order to gain an understanding of Amplichip, how the device works, the benefits of Amplichip, and the technology's limitations will all be addressed in my presentation.

This document is currently not available here.

Share

COinS
 
Apr 26th, 8:30 AM Apr 26th, 10:00 AM

Amplichip: Diagnostic Tool of the Future

CSU 204

Adverse drug reactions, or ADRs, are the fourth leading cause of death in the. United-States according to Drug Discovery and Development of October 1, 2004, but new technology provides an opportunity to change that statistic. Personalized medicine, has the huge potential to change the lives of millions of people with a testing device manufactured by Roche Diagnostics known as Amplichip. Amplichip is a simple blood-testing device that provides doctors with important information about how patients process medications. Heino von Prondzynski, CEO of Roche Diagnostics, says of Amplichip, "The use of this test takes a big-step forward in making personalized medicine a reality n and has the potential to improve patient outcomes." Testing with Amplichip will soon be a routine diagnostic procedure that will have impact on millions of people. In order to gain an understanding of Amplichip, how the device works, the benefits of Amplichip, and the technology's limitations will all be addressed in my presentation.